Dachaigh › Luchd-obrach › CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir CytomX Therapeutics, Inc. 10 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 9. Tuarastal meadhanach a chaidh a thabhann: $156,347.
A bheil CytomX Therapeutics, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir CytomX Therapeutics, Inc. 10 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 15 Ògmh 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Iarrtasan cairt uaine (PERM) aig CytomX Therapeutics, Inc.: 3 →
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Senior Research Associate | 3 | $107,370 |
| Manager, Clinical Data Management | 2 | $175,590 |
| Scientist II, Oncology | 1 | $127,000 |
| Vice President, Business Development | 1 | $290,000 |
| Senior Manager, Regulatory Affairs and Operations | 1 | $172,489 |
| Associate Scientist, Protein Sciences | 1 | $112,000 |
| Associate Director, Clinical Operations | 1 | $193,170 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 1 | $127,000 |
| FY2024 | 7 | $156,347 |
| FY2026 | 2 | $194,834 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Molecular and Cellular Biologists3
- Data Scientists2
- Biochemists and Biophysicists2
- Marketing Managers1
- Regulatory Affairs Managers1
- Natural Sciences Managers1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Senior Research Associate | $117,916–$140,217 Ìre II | Emeryville, CA | 15 Ògmh 2026 | 1 Dàmh 2026 | Air a tharraing air ais |
| Manager, Clinical Data Management | $194,834–$215,000 Ìre IV | Emeryville, CA | 12 Ògmh 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Associate Director, Clinical Operations | $193,170–$221,000 Ìre II | South San Francisco, CA | 20 Sult 2024 | 20 Màrt 2025 | Dearbhaichte |
| Senior Research Associate | $109,741–$135,000 Ìre II | South San Francisco, CA | 25 Ògmh 2024 | 20 Dùbh 2024 | Dearbhaichte |
| Senior Manager, Regulatory Affairs and Operations | $172,489–$185,000 | South San Francisco, CA | 8 Cèit 2024 | 23 Lùna 2024 | Dearbhaichte |
| Manager, Clinical Data Management | $156,347–$190,000 | Belmont, CA | 1 Cèit 2024 | 4 Dàmh 2024 | Dearbhaichte |
| Associate Scientist, Protein Sciences | $112,000–$135,000 Ìre II | South San Francisco, CA | 1 Cèit 2024 | 1 Dàmh 2024 | Dearbhaichte |
| Vice President, Business Development | $290,000–$330,000 Ìre IV | South San Francisco, CA | 21 Màrt 2024 | 8 Gibl 2024 | Dearbhaichte |
| Senior Research Associate | $105,000–$135,000 Ìre II | South San Francisco, CA | 19 Màrt 2024 | 7 Sult 2024 | Dearbhaichte |
| Scientist II, Oncology | $127,000–$161,000 Ìre III | South San Francisco, CA | 6 Màrt 2023 | 3 Lùna 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).